Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers.
| Autor: | Guix M, Granja Nde M, Meszoely I, Adkins TB, Wieman BM, Frierson KE, Sanchez V, Sanders ME, Grau AM, Mayer IA, Pestano G, Shyr Y, Muthuswamy S, Calvo B, Krontiras H, Krop IE, Kelley MC, Arteaga CL |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2/20/2008, Vol. 26 Issue 6, p897-906, 10p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|